Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huanglian Decoction is a traditional Chinese medicine (TCM) prescription originating from the Treatise on Febrile Diseases. It is primarily used for treating digestive system diseases, such as stress ulcers and gastrointestinal mucosal lesions. The formula typically consists of Coptis chinensis (Huanglian), Glycyrrhiza uralensis (Gancao), Zingiber officinale (Shengjiang), and sometimes other herbs depending on the specific historical source or clinical application[4]. Huanglian Decoction exerts its effects by repairing gastric mucosal injury, regulating inflammatory cytokines such as TNF-α and IL-1, increasing intestinal probiotics, and promoting gut microbiota homeostasis. Its pharmacological actions include anti-inflammatory effects, modulation of the intestinal microbiome, and support for gastrointestinal mucosal healing[4]. The mechanism involves reducing pro-inflammatory cytokines in damaged tissue and enhancing beneficial bacterial populations in the gut.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huanglian decoction.